The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Avdeev S.N.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Pulmonology Research Institute of the Federal Medical-Biological Agency of Russia;
National Medical Research Center of Cardiology named after Academician E.I. Chazov

Boytsov S.A.

Chazov National Medical Research Center of Cardiology

Gorelov A.V.

Central Research Institute of Epidemiology;
Russian University of Medicine

Drozdova L.Yu.

National Medical Research Center for Therapy and Preventive Medicine

Kozlov R.S.

Smolensk State Medical University

Lila A.M.

Russian Medical Academy of Continuing Professional Education;
V.A. Nasonova Research Institute of Rheumatology

Namazova-Baranova L.S.

N.I. Pirogov Russian National Research Medical University (Pirogov University);
Petrovsky National Research Centre of Surgery

Nikonova T.V.

I.I. Dedov National Medical Research Center of Endocrinology

Polibin R.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Rudakova A.V.

Children’s Scientific and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency;
Saint Petersburg State Chemical Pharmaceutical University

Tkacheva O.N.

Pirogov Russian National Research Medical University

Chulanov V.P.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
National Medical Research Center of Phthisiopulmonology and Infectious Diseases

Vaccination against pneumococcal infection as a mean of reducing morbidity and mortality of the adult population from risk groups in the Russian Federation. (Resolution of the Council of Experts)

Authors:

Drapkina O.M., Avdeev S.N., Boytsov S.A., Gorelov A.V., Drozdova L.Yu., Kozlov R.S., Lila A.M., Namazova-Baranova L.S., Nikonova T.V., Polibin R.V., Rudakova A.V., Tkacheva O.N., Chulanov V.P.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(7): 7‑14

Read: 2626 times


To cite this article:

Drapkina OM, Avdeev SN, Boytsov SA, et al. Vaccination against pneumococcal infection as a mean of reducing morbidity and mortality of the adult population from risk groups in the Russian Federation. (Resolution of the Council of Experts). Russian Journal of Preventive Medicine. 2025;28(7):7‑14. (In Russ.)
https://doi.org/10.17116/profmed2025280717

Recommended articles:
Analysis of morbidity in the Gomel region of Repu­blic Bela­rus. Russian Journal of Preventive Medi­cine. 2025;(9):23-28
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Current global trends in the epidemiology of inflammatory bowel diseases. Russian Journal of Evidence-Based Gastroenterology. 2025;(3):104-117

References:

  1. Avdeev SN, Alyeva MH, Baranov AA, et al. Federal Clinical Guidelines on Vaccination of pneumococcal infection in children and adults. Russian Journal of Preventive Medicine. 2023;26(9-2):3-23. (In Russ.). https://doi.org/10.17116/profmed2023260923
  2. Briko NI, Korshunov VA, Lomonosov KS. Pneumococcal Infection in Russia: State of the Issue. Vestnik RAMN. 2021;76(1):28-42. (In Russ.). https://doi.org/10.15690/vramn1404
  3. Korovkin AS, Obukhov YuI, Syatchikhina EN. Approaches to vaccination of adults against pneumococcal disease in different countries of the world. Zhurnal infektologii. 2024;16(2):5-16. (In Russ.). https://doi.org/10.22625/2072-6732-2024-16-2-5-16
  4. Rudakova AV, Briko NI, Lobzin YuV, et al. Cost-effectiveness of vaccination of elderly citizens against pneumococcal infection in the Russian Federation. Russian Journal of Preventive Medicine. 2021;24(12):41-48. (In Russ.). https://doi.org/10.17116/profmed20212412141
  5. O sostoyanii sanitarno-e’pidemiologicheskogo blagopoluchiya naseleniya v Rossijskoj Federacii v 2023 godu. Gosudarstvenny’j doklad. M.: Federal’naya sluzhba po nadzoru v sfere zashhity’ prav potrebitelej i blagopoluchiya cheloveka; 2024. Accessed July 04, 2025. (In Russ.). https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=27779
  6. Klinicheskie rekomendacii. Virusny’e pnevmonii. ID 838_1. 2024. Accessed July 04, 2025. (In Russ.). https://cr.minzdrav.gov.ru/preview-cr/838_1
  7. Ocenka zabolevaemosti, rasprostranennosti otdel’ny’x zabolevanij i kadrovoj obespechennosti sistemy’ zdravooxraneniya v Rossijskoj Federacii v 2023 godu. Otchet po nauchno-issledovatel’skoj rabote. M., FGBU «CzNIIOIZ»; 2024. (In Russ.).
  8. Davydenko MA, Churilova NS, Koroleva IS. Epidemiological Manifestations of Purulent Bacterial Meningitis in the Russian Federation. Jepidemiologija i vakcinoprofilaktika. 2024;23(5):33-41. (In Russ.). https://doi.org/10.31631/2073-3046-2024-23-5-33-41
  9. The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in Adults. Kyaw MH, et al. Journal of Infectious Diseases. 2005;192:377-386.  https://doi.org/10.1086/431521
  10. Podzolkov VI, Dragomiretskaya NA, Medvedev ID, et al. Levels of cardiac biomarkers and three-year survival rate in hospitalized patients with heart failure and community-acquired pneumonia. Rossijskij kardiologicheskij zhurnal. 2024;29(6):5875. (In Russ.). https://doi.org/10.15829/1560-4071-2024-5875
  11. Marra F, Zhang A, Gillman E, et al. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis. International Journal of Infectious Diseases. 2020;99:204-213.  https://doi.org/10.1016/j.ijid.2020.07.038
  12. Rudakova AV, Brico NI, Lobzin YuV, et al. Cost-effectiveness of pneumococcal vaccination among patients with chronic heart failure. Kardiologiia. 2023;63(5):19-26. (In Russ.). https://doi.org/10.18087/cardio.2023.5.n2378
  13. Jaiswal V, Ang SP, Lnu K, et al. Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022;11(13):3799. https://doi.org/10.3390/jcm11133799
  14. Immunizaciya vzrosly’x. Metodicheskie rekomendacii. O.M. Drapkina, N.I. Briko, M.P. Kostinov, i dr. M.: FGBU «NMICz TPM» Minzdrava Rossii; 2020. (In Russ.).
  15. Shestakova MV, Nikonova TV, Barysheva VO, et al. Vaccination of patients with diabetes mellitus. Saharnyj diabet. 2022;25(1):50-60. (In Russ.). https://doi.org/10.14341/DM12833
  16. Tarasova AA, Kostinov MP, Paramonova JA. Approaches to vaccine prophilaxis of respiratory infections in patients with diabetes mellitus in the modern epidemiological situation. Saharnyj diabet. 2019;22(5):473-480. (In Russ.). https://doi.org/10.14341/DM9820
  17. Romanovskikh AG, Sinopalnikov AI, Belotserkovskaya YuG, et al. Infectious Exacerbation of Chronic Obstructive Pulmonary Disease: Antibacterial Therapy in Outpatient Settings. Prakticheskaja pul’monologija. 2022;2; 16-24. (In Russ.). https://doi.org/10.24412/2409-6636-2022-12939
  18. Deev IA, Kobyakova OS, Starodubov VI i dr. Zabolevaemost’ vsego naseleniya Rossii v 2023 godu: statisticheskie materialy’. M.: FGBU «CzNIIOIZ» Minzdrava Rossii; 2024. (In Russ.).
  19. Ignatova GL, Avdeev SN, Antonov VN, et al. Ten-year analysis of the efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease. Pul’monologija. 2023;33(6):750-758. (In Russ.). https://doi.org/10.18093/0869-0189-2023-33-6-750-758
  20. Kostinov MP, Elagina TN, Filatov NN, et al. Expected epidemiological and clinical effects of vaccination against pneumococcal infection in Russia. Infekcionnye bolezni: Novosti. Mnenija. Obuchenie. 2018;7(2):107-114. (In Russ.). https://doi.org/10.24411/2305-3496-2018-12013
  21. Prikaz Ministerstva zdravooxraneniya Rossijskoj Federacii ot 6 dekabrya 2021g. №1122n «Ob utverzhdenii nacional’nogo kalendarya profilakticheskix privivok, kalendarya profilakticheskix privivok po e’pidemicheskim pokazaniyam i poryadka provedeniya profilakticheskix privivok». Accessed July 04, 2025. (In Russ.).
  22. Ukaz Prezidenta Rossijskoj Federacii ot 07.05.2024 g. №309 «O nacional’ny’x celyax razvitiya Rossijskoj Federacii na period do 2030 goda i na perspektivu do 2036 goda». Accessed July 04, 2025. (In Russ.). https://www.kremlin.ru/acts/bank/50542
  23. Strategiya razvitiya immunoprofilaktiki infekcionny’x boleznej na period do 2035 goda. Utverzhdena rasporyazheniem Pravitel’stva Rossijskoj Federacii ot 18 sentyabrya 2020 g. №2390-r. Accessed July 04, 2025. (In Russ.). https://static.government.ru/media/files/Zz7brckXMkAQTZHTA6ixAxlY4lhYBEeM.pdf
  24. Plan meropriyatij po realizacii Strategii razvitiya immunoprofilaktiki infekcionny’x boleznej na period do 2035 goda. Utverzhden rasporyazheniem Pravitel’stva Rossijskoj Federacii ot 29.03.21 №774-r.Accessed July 04, 2025. (In Russ.). https://government.ru/docs/all/133587/
  25. Briko NI, Korshunov VA, Lobzin JV, et al. A Decade of Experience in the use of 13-Valent Conjugated Polysaccharide Pneumococcal Vaccine in Russian Federation. Jepidemiologija i vakcinoprofilaktika. 2023;22(4):106-139. (In Russ.). https://doi.org/10.31631/2073-3046-2023-22-4-106-139
  26. Rudakova AV, Briko NI, Lobzin YuV, et al. Vaccination against pneumococcal infections in Russian Federation: social and pharmacoeconomic aspects. Zhurnal infektologii. 2018;10(3):11-22. (In Russ.). https://doi.org/10.22625/2072-6732-2018-10-3-11-22
  27. McLaughlin J, Jiang Q, Isturiz RE, et al. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design. Clinical Infectious Diseases. 2018;67(10): 1498-1506. https://doi.org/10.1093/cid/ciy312
  28. Kurkova AA, Muraviov AA, Kozlov RS. The current status of antimicrobial resistance of Streptococcus pneumoniae and specific vaccine prevention of pneumococcal infection. Pul’monologija. 2023;33(4):534-541. (In Russ.). https://doi.org/10.18093/0869-0189-2022-3655
  29. Rudakova AV, Briko NI, Lobzin YuV, et al. Cost-Effectiveness of Pneumococcal Vaccination among Patients with Diabetes Mellitus. Jepidemiologija i vakcinoprofilaktika. 2022;21(5):78-88. (In Russ.). https://doi.org/10.31631/2073-3046-2022-21-5-78-88

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.